Evidence map›Paper›PMID 27924603›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2017

Differential Expression and Functional Analysis of High-Throughput -Omics Data Using Open Source Tools.

Moritz Kebschull, Melanie Julia Fittler, Ryan T Demmer, Panos N Papapanou

Open access · greenAbstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Crosstalk BetweenFrontiers in pharmacology · 2021
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Moritz KebschullDepartment of Periodontology, Operative and Preventive Dentistry, Faculty of Medicine, University of Bonn, Welschnonnenstr. 17, Bonn, D-53111, Germany. moritz.kebschull@uni-bonn.de.
Melanie Julia FittlerDepartment of Periodontology, Operative and Preventive Dentistry, University of Bonn, Welschnonnenstr. 17, Bonn, D-53111, Germany.
Ryan T DemmerDepartment of Epidemiology, Columbia University Mailman School of Public Health, New York, NY, USA.
Panos N PapapanouDivision of Periodontics, Section of Oral, Diagnostic and Rehabilitation Sciences, Columbia University College of Dental Medicine, New York, NY, USA.
Columbia University · USUniversity of Bonn · DE

Funding

Gene Expression in Chronic and Aggressive PeriodontitisR01DE015649 · NIDCR · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI PAPAPANOU, PANOS N · 2004 to 2006
$1.8M
Genomic approaches to the pathobiology and classification of periodontitisR03DE024735 · NIDCR · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI PAPAPANOU, PANOS N · 2015 to 2016
$480k
MicroRNA expression in gingival tissues in periodontal health and diseaseR21DE021820 · NIDCR · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI PAPAPANOU, PANOS N · 2012 to 2013
$432k
NIDCR NIH HHS R01 DE015649NIDCR NIH HHS R03 DE024735NIDCR NIH HHS R21 DE021820
6 · The paper itself

Abstract

Today, -omics analyses, including the systematic cataloging of messenger RNA and microRNA sequences or DNA methylation patterns in a cell population, organ, or tissue sample, allow for an unbiased, comprehensive genome-level analysis of complex diseases, offering a large advantage over earlier "candidate" gene or pathway analyses. A primary goal in the analysis of these high-throughput assays is the detection of those features among several thousand that differ between different groups of samples. In the context of oral biology, our group has successfully utilized -omics technology to identify key molecules and pathways in different diagnostic entities of periodontal disease.A major issue when inferring biological information from high-throughput -omics studies is the fact that the sheer volume of high-dimensional data generated by contemporary technology is not appropriately analyzed using common statistical methods employed in the biomedical sciences.In this chapter, we outline a robust and well-accepted bioinformatics workflow for the initial analysis of -omics data generated using microarrays or next-generation sequencing technology using open-source tools. Starting with quality control measures and necessary preprocessing steps for data originating from different -omics technologies, we next outline a differential expression analysis pipeline that can be used for data from both microarray and sequencing experiments, and offers the possibility to account for random or fixed effects. Finally, we present an overview of the possibilities for a functional analysis of the obtained data.

Indexed as

Gene Expression RegulationSoftwareWeb BrowserComputational BiologyDatabases, Nucleic AcidGene Expression ProfilingGene Regulatory NetworksGenomicsHigh-Throughput Nucleotide SequencingSequence Analysis, RNADifferential expression analysisDNA methylationFunctional groupsGene expressionGingivaMicroarraymicroRNANext-generation sequencingPeriodontal diseaseTranscriptome

Identifiers

PMID27924603
PMCPMC6554642
OpenAlexW2559987216

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.